🚀 VC round data is live in beta, check it out!
Xiamen Comfort Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for Xiamen Comfort Science and similar public comparables like Koshidaka Holdings, Tivoli, Tourism Holdings, Hollywood Bowl Group and more.
Xiamen Comfort Science Overview
About Xiamen Comfort Science
Xiamen Comfort Science and Technology Group Co Ltd is a China based company operating in the industries of health massage, health environment, home medical care, and others. The company is principally engaged in manufacturing massage healthcare product like massage chairs. It also offers products in the areas of healthy environment like humidifier, and health monitoring like weight analysis device. The company sells its products in China and other international countries. Some of the company's brands are Ogawa, Cozzia, Fuji, Fujimedic, and Medisana.
Founded
1996
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$557M
Xiamen Comfort Science Financials
Xiamen Comfort Science reported last 12-month revenue of $800M and EBITDA of $66M.
In the same LTM period, Xiamen Comfort Science generated $284M in gross profit, $66M in EBITDA, and $17M in net income.
Revenue (LTM)
Xiamen Comfort Science P&L
In the most recent fiscal year, Xiamen Comfort Science reported revenue of $708M and EBITDA of $60M.
Xiamen Comfort Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $800M | XXX | $708M | XXX | XXX | XXX |
| Gross Profit | $284M | XXX | $255M | XXX | XXX | XXX |
| Gross Margin | 35% | XXX | 36% | XXX | XXX | XXX |
| EBITDA | $66M | XXX | $60M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $17M | XXX | $9M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $49M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Xiamen Comfort Science Stock Performance
Xiamen Comfort Science has current market cap of $567M, and enterprise value of $557M.
Market Cap Evolution
Xiamen Comfort Science's stock price is $0.91.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $557M | $567M | -1.8% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialXiamen Comfort Science Valuation Multiples
Xiamen Comfort Science trades at 0.7x EV/Revenue multiple, and 8.5x EV/EBITDA.
EV / Revenue (LTM)
Xiamen Comfort Science Financial Valuation Multiples
As of April 11, 2026, Xiamen Comfort Science has market cap of $567M and EV of $557M.
Equity research analysts estimate Xiamen Comfort Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Xiamen Comfort Science has a P/E ratio of 34.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $567M | XXX | $567M | XXX | XXX | XXX |
| EV (current) | $557M | XXX | $557M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.5x | XXX | 9.3x | XXX | XXX | XXX |
| EV/EBIT | 26.8x | XXX | 42.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.2x | XXX | XXX | XXX |
| P/E | 34.2x | XXX | 60.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (42.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Xiamen Comfort Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Xiamen Comfort Science Margins & Growth Rates
Xiamen Comfort Science's revenue in the last 12 month grew by 9%.
Xiamen Comfort Science's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Xiamen Comfort Science's rule of X is 31% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Xiamen Comfort Science Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 31% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 8% | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Xiamen Comfort Science Public Comps
See public comps and valuation multiples for other Lifestyle & Recreation comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Koshidaka Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Tivoli | XXX | XXX | XXX | XXX | XXX | XXX |
| Tourism Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Hollywood Bowl Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Marcus | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Xiamen Comfort Science M&A Activity
Xiamen Comfort Science acquired XXX companies to date.
Last acquisition by Xiamen Comfort Science was on XXXXXXXX, XXXXX. Xiamen Comfort Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Xiamen Comfort Science
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialXiamen Comfort Science Investment Activity
Xiamen Comfort Science invested in XXX companies to date.
Xiamen Comfort Science made its latest investment on XXXXXXXX, XXXXX. Xiamen Comfort Science invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Xiamen Comfort Science
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Xiamen Comfort Science
| When was Xiamen Comfort Science founded? | Xiamen Comfort Science was founded in 1996. |
| Where is Xiamen Comfort Science headquartered? | Xiamen Comfort Science is headquartered in China. |
| Is Xiamen Comfort Science publicly listed? | Yes, Xiamen Comfort Science is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Xiamen Comfort Science? | Xiamen Comfort Science trades under 002614 ticker. |
| When did Xiamen Comfort Science go public? | Xiamen Comfort Science went public in 2011. |
| Who are competitors of Xiamen Comfort Science? | Xiamen Comfort Science main competitors are Koshidaka Holdings, Tivoli, Tourism Holdings, Hollywood Bowl Group. |
| What is the current market cap of Xiamen Comfort Science? | Xiamen Comfort Science's current market cap is $567M. |
| What is the current revenue of Xiamen Comfort Science? | Xiamen Comfort Science's last 12 months revenue is $800M. |
| What is the current revenue growth of Xiamen Comfort Science? | Xiamen Comfort Science revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Xiamen Comfort Science? | Current revenue multiple of Xiamen Comfort Science is 0.7x. |
| Is Xiamen Comfort Science profitable? | Yes, Xiamen Comfort Science is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Xiamen Comfort Science? | Xiamen Comfort Science's last 12 months EBITDA is $66M. |
| What is Xiamen Comfort Science's EBITDA margin? | Xiamen Comfort Science's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Xiamen Comfort Science? | Current EBITDA multiple of Xiamen Comfort Science is 8.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.